Contact US

Amnio-Maxx is an all-natural liquid matrix allograft derived from amniotic fluid. Naturally present to protect the fetus, amniotic fluid provides the ideal environment to support fetal growth [Figure 1].1 The cushioning effect of amniotic fluid in utero shields the fetus from outside pressures, acting as a shock absorber.2

Much the same as the in utero environment, Amnio-Maxx principally functions to cushion surface articulation within the joint capsule. The most essential functions of the joint capsule are to provide shock absorption, lubrication, and joint stability. When injury or degradation causes cushioning to decline, discomfort can result as the body's natural shock absorbers wear out.3

Amnio-Maxx harnesses the natural cushioning properties of amniotic fluid to deliver the same support to joint capsules. Delivered to provide supplementation, Amnio-Maxx helps to protect joints by supporting the overall function of the joint capsule. Clinically, Amnio-Maxx has been used successfully across the orthopaedic space with an impeccable safety record.

Safety and Versatility
  • Amniotic fluid is recovered with consent from healthy mothers who have undergone Cesarean section delivery.
  • Amnio-Maxx is processed using minimally manipulative procedures that have been shown to successfully preserve the natural composition of amniotic fluid.
  • E-Beam terminal sterilization provides a sterility assurance level (SAL) of 10.-6
bubble 01

Ambient Temperature, 2ºC to 30ºC
Two-year shelf-life
Final product provided in convenient and easy-to-use vial [Figure 2]
Easily applied with a 30G or larger needle directly to the administration site
Intended to provide cushioning within joint capsules when a physician
concludes that such function is medically indicated

Ordering Information
bubble 02
Amnio-Maxx Liquid Amnion
Ambient Temperature (2ºC to 30ºC)
AMRT-1Amnio-Maxx Liquid Amnion (1.0mL)
AMRT-2Amnio-Maxx Liquid Amnion (2.0mL)
  1. Seeds AE: Amniotic fluid physiology in Sciarra JJ (ed): Gynecology and Obstetrics, Vol 3. New York, Harper & Row, 1989.
  2. Shahnazi M, et al., The Effects of Intravenous Hydration on Amniotic Fluid Volume and Pregnancy Outcomes in Women with Term Pregnancy and Oligohydramnios: A Randomized Clinical Trial. Journal of Caring Sciences.
    September 2012; 1(3): 123-128.
  3. Hui, A.Y., et al., A Systems Biology Approach to Synovial Joint Lubrication in Health, Injury, and Disease. Wiley Interdisc Rev Syst Biol Med. 2012; 4(1): 15-37.